Cardiology

Undiagnosed heart condition affects up to one in six older Black men with heart failure, new research finds.

Occlusion procedure offers safer stroke prevention than anticoagulants for dialysis patients with kidney failure, new study finds.

Abelacimab reduces bleeding risk in atrial fibrillation patients, even with kidney disease, study finds.

Learn if post-heart attack H. pylori screening prevents gastrointestinal bleeding and who might benefit. Keep reading for insights.

Women remain underrepresented in heart trials, a global review finds, risking gaps in tailored cardiovascular care and outcomes.

Find out how app-based messaging supports diabetes management and reduces cardiovascular risks in adults with poor control. Keep reading.

AF screening with an ECG patch led to a modest increase in AF diagnosis at 2.5 years

Understand how chamber volume ratios on MRI predict cardiac risk, even when heart chambers fall within normal size limits.

The MAPLE-HCM trial shows aficamten improves exercise capacity and symptoms more than metoprolol in symptomatic obstructive hypertrophic cardiomyopathy.

In-hospital initiation of SGLT2 inhibitors is safe and may lower early cardiovascular death, worsening heart failure, and mortality in hospitalised patients.

The POTCAST trial shows raising plasma potassium to high-normal levels reduces ventricular arrhythmia risk, hospitalisations, and death in ICD patients.

DIGIT-HF shows digitoxin reduces death and hospitalisation in advanced heart failure, offering an additional option for high-risk patients on top of standard therapy.

A large study finds age strongly increases arrhythmia risk, while higher fitness levels protect against atrial ectopy in asymptomatic adults.

Automatic chest compression devices outperform manual methods for CPR in simulated zero gravity, with piston devices meeting guideline-recommended standards.

A major analysis finds Afro-American patients with hypertension face higher cardiovascular morbidity, while Asian patients carry a greater risk of stroke.

COVID-19 survivors, especially women, show signs of vascular ageing, highlighting new risks for long-term heart health.

Nonviral gene therapy to boost brown fat molecule reverses age-related heart dysfunction in animal studies.

Study finds no long-term cardiovascular benefit from aspirin in healthy older people, but highlights increased bleeding risk.

Wearables reveal unique activity and heart rate patterns in long COVID, showing promise as clinical biomarkers.

Semaglutide improves cardiovascular risk factors but raises health care costs, finds large multicentre cohort study.

CPAP therapy lowers cardiovascular risks in high-risk obstructive sleep apnoea patients, new multi-trial study finds.

Discover the higher risk of heart failure with pregabalin versus gabapentin in older adults. Read the full study findings.

Early cardiac rehabilitation did not improve function or rehospitalisation in severe heart failure, but mobility gains were seen.

Adults later diagnosed with cardiovascular disease show declining activity years before onset, highlighting the importance of lifelong exercise.

Tirzepatide improves outcomes in heart failure with obesity, with greatest physical benefits seen in those with higher BMI.

US heart deaths have dropped since 1970, but deaths from heart failure and arrhythmias are on the rise.

Discover how LMNA gene variant type and position impact cardiomyopathy risk—keep reading for clinical implications and treatment guidance.

Delayed hypertension diagnosis increases cardiovascular risk and lowers treatment rates, underscoring the value of prompt clinical action.

Discover how bedtime antihypertensive dosing benefits blood pressure control. Keep reading for clinical insights and recommendations.

AI screening from a single echocardiographic clip accurately detects cardiac amyloidosis, surpassing traditional diagnostic methods.

MAARS uniquely integrates electronic health records, imaging reports, and contrast-enhanced cardiac MRI using a transformer-based neural network.

GLP-1 receptor agonists cut heart, stroke, and kidney risks in people with MGUS and diabetes, new study finds.

Find out how epinephrine administration routes impact survival in paediatric cardiac arrest—explore the latest evidence now.

AI now matches experts in echocardiogram interpretation, promising faster, more accessible heart diagnostics for all patients.

Finerenone benefits heart failure patients with preserved ejection fraction, regardless of frailty, supporting its wider clinical use.

Edoxaban and rivaroxaban show best balance of efficacy and safety in elderly patients with atrial fibrillation.

Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks remain unchanged.

Loneliness increases heart disease risk by 15% in both US and South Korea, major study finds.

Beta-blocker interruption after heart attack raises blood pressure and heart rate, increasing risks especially in hypertensive patients.

Timing doesn’t matter! Study finds no added heart benefit from bedtime blood pressure meds.

Understand how the DASH diet significantly lowers the risk of colorectal cancer, supporting dietary changes for cancer prevention.

Discover how yoga may reduce blood pressure, but further investigation is needed to validate these results.

SGLT2 inhibitors reduce hyperkalemia risk, aiding RAASi continuity in high-risk patients.

A new study has revealed a potential link between live zoster vaccination and a reduced risk of cardiovascular disease.

New risk model predicts hyperkalaemia in CKD and diabetes, enabling tailored care and safer treatment decisions for patients.

Pregnancies with mechanical heart valves carry high risks, as a global registry reveals stark outcomes.

Rising systolic blood pressure variability increases risks of heart disease, kidney disease, and death.

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Clinical trial results reveal that etripamil cuts emergency department visits by 39% inpatients with paroxysmal supraventricular tachycardia.

Early GDMT goals, especially blood pressure control, reduce the risk of CV events in chronic coronary disease.

New study shows all ADHD medications, not just stimulants, affect cardiovascular parameters in children, adolescents, and adults.

Wearable ECG shirt monitors heart rate recovery, predicting cardiovascular risk with 86% accuracy in new study.

Research reveals that hypertensive pregnancy disorders double dilated cardiomyopathy risk; highlighting that vigilance is needed postpartum.

Genetic study with 796,722 participants reveals that remnant cholesterol drives PAD risk independently.

Discover how 60 genes drive congenital heart disease. Learn how genetic testing improves outcomes.

OAC discontinuation post-catheter ablation for AF reduces bleeding but increases thromboembolic risk.

A new study shows that compound heatwaves drive linear cardiac mortality risks, surpassing daytime/night-only events.

New research shows how the FAB Score predicts mortality risk in adult Fontan patients with 92% accuracy.

Machine learning model predicts death risk in broken heart syndrome with 84% accuracy, a new study reveals.

Novel metabolic accelerator HU6 reduces fat mass without muscle loss in obesity-related heart failure patients.

Research suggests statins significantly reduce liver cancer and decompensation risk in chronic liver disease patients, especially with prolonged use.

Quitting alcohol raises bad cholesterol while lowering good cholesterol, study finds.

SCAD study flags risky blood thinners, fibromuscular dysplasia as predictors of heart complications. Urges treatment rethink.

Butter linked to higher mortality; plant-based oils reduce death risks. Study urges dietary swaps for long-term health.

Long-term study reveals alarming cardiovascular risks in steroid users, with some heart conditions up to nine times more likely.

Study finds no increased risk of major cardiovascular events with nicotinamide use but highlights risks for prior MACE patients.

Arterial stiffness, measured by pulse wave velocity, is more strongly linked to ageing than short-term blood pressure variability.

New study finds the PERIXa protocol for perioperative anticoagulation in AF patients undergoing low-risk procedures is safe.

Myocardial fibrosis predicts mortality after aortic valve replacement, highlighting its importance for risk assessment in aortic stenosis.

A groundbreaking study from the European Society of Cardiology suggests that pregnancy in women with peri-partum cardiomyopathy (PPCM) may not be as high-risk as previously believed.

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

Olpasiran significantly lowers oxidized phospholipids on apolipoprotein B but has no impact on systemic inflammatory markers in cardiovascular disease.